Marta Vidal

2.9k total citations
70 papers, 623 citations indexed

About

Marta Vidal is a scholar working on Finance, Economics and Econometrics and Infectious Diseases. According to data from OpenAlex, Marta Vidal has authored 70 papers receiving a total of 623 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Finance, 20 papers in Economics and Econometrics and 16 papers in Infectious Diseases. Recurrent topics in Marta Vidal's work include Financial Markets and Investment Strategies (30 papers), SARS-CoV-2 and COVID-19 Research (16 papers) and Corporate Finance and Governance (15 papers). Marta Vidal is often cited by papers focused on Financial Markets and Investment Strategies (30 papers), SARS-CoV-2 and COVID-19 Research (16 papers) and Corporate Finance and Governance (15 papers). Marta Vidal collaborates with scholars based in Spain, United States and Mexico. Marta Vidal's co-authors include Javier Vidal-García, Sabri Boubaker, Carlota Dobaño, Ruth Aguilar, Gazi Salah Uddin, Gemma Moncunill, Luís Izquierdo, Alfons Jiménez, Natalia Rodrigo Melero and Carlo Carolis and has published in prestigious journals such as Nature Communications, PLoS ONE and Scientific Reports.

In The Last Decade

Marta Vidal

57 papers receiving 614 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marta Vidal Spain 14 185 171 115 100 72 70 623
Phạm Thị Hoàng Anh Vietnam 14 32 0.2× 34 0.2× 49 0.4× 36 0.4× 52 0.7× 29 870
Megumi Kubota Japan 10 111 0.6× 26 0.2× 114 1.0× 26 0.3× 22 0.3× 31 563
Xi Gao China 6 34 0.2× 17 0.1× 34 0.3× 73 0.7× 24 0.3× 30 389
Han Zhao China 12 11 0.1× 102 0.6× 56 0.5× 13 0.1× 22 0.3× 24 327
George Tadeu Nunes Diniz Brazil 13 25 0.1× 157 0.9× 27 0.2× 3 0.0× 67 0.9× 56 433
John L. Simpson Australia 10 113 0.6× 66 0.4× 155 1.3× 46 0.5× 32 0.4× 50 479
Min S. Kim United States 13 76 0.4× 16 0.1× 47 0.4× 54 0.5× 86 1.2× 30 712
Rodrigo Cerda Chile 11 33 0.2× 275 1.6× 189 1.6× 60 0.6× 20 0.3× 46 593
Carsten Köhler Germany 12 18 0.1× 101 0.6× 42 0.4× 3 0.0× 142 2.0× 37 443

Countries citing papers authored by Marta Vidal

Since Specialization
Citations

This map shows the geographic impact of Marta Vidal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marta Vidal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marta Vidal more than expected).

Fields of papers citing papers by Marta Vidal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marta Vidal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marta Vidal. The network helps show where Marta Vidal may publish in the future.

Co-authorship network of co-authors of Marta Vidal

This figure shows the co-authorship network connecting the top 25 collaborators of Marta Vidal. A scholar is included among the top collaborators of Marta Vidal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marta Vidal. Marta Vidal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alemany, Andrea, Edwards Pradenas, Ruth Aguilar, et al.. (2025). Patient and donor antibody profiles in early COVID-19 convalescent plasma therapy in the COnV-ert trial. Frontiers in Immunology. 16. 1647488–1647488.
2.
Ramírez‐Morros, Anna, Marta Vidal, D. Herbert Opi, et al.. (2025). Post-vaccination IgG4 and IgG2 class switch associates with increased risk of SARS-CoV-2 infections. Journal of Infection. 90(4). 106473–106473. 8 indexed citations
3.
Ramírez‐Morros, Anna, Alfons Jiménez, Marta Vidal, et al.. (2025). Determinants of antibody levels and protection against omicron BQ.1/XBB breakthrough infection. Communications Medicine. 5(1). 243–243.
4.
Pino, Rosa, Víctor Urrea, Marta Vidal, et al.. (2025). Tracking the soluble biomarkers of MIS-C and their association with clinical parameters and severity. Pediatric Research.
5.
Vidal-García, Javier & Marta Vidal. (2025). A Review of the Capital Asset Pricing Model. SSRN Electronic Journal.
6.
Ranzani, Otávio T., Rocío Rubio, Anna Ramírez‐Morros, et al.. (2025). Primary SARS-CoV-2 exposure by vaccination or infection shapes immune responses to omicron variants among a Spanish cohort. Nature Communications. 17(1). 863–863. 1 indexed citations
7.
Rubio, Rocío, Dídac Macià, Diana Barrios, et al.. (2024). High-resolution kinetics and cellular determinants of SARS-CoV-2 antibody response over two years after COVID-19 vaccination. Microbes and Infection. 27(2). 105423–105423. 5 indexed citations
9.
Karachaliou, Marianna, Ana Espinosa, Xavier Farré, et al.. (2024). Mental illness and antibody responses after COVID-19 vaccination in a prospective population-based study in Catalonia. Vaccine. 45. 126591–126591.
10.
Pembrey, Lucy, Mariona Bustamante, Ruth Aguilar, et al.. (2024). The association of Helicobacter pylori with adverse pregnancy outcomes in three European birth cohorts. BMC Pregnancy and Childbirth. 24(1). 745–745. 1 indexed citations
11.
Ribes, Marta, Marta Vidal, Ruth Aguilar, et al.. (2023). Seroprevalence and socioeconomic impact of the first SARS-CoV-2 infection wave in a small town in Navarre, Spain. Scientific Reports. 13(1). 3862–3862. 1 indexed citations
12.
Vidal-García, Javier & Marta Vidal. (2022). Information and Volatility in Financial Markets. SSRN Electronic Journal. 1 indexed citations
13.
Vidal-García, Javier & Marta Vidal. (2022). Financial Market Anomalies. SSRN Electronic Journal.
14.
Dobaño, Carlota, Anna Ramírez‐Morros, Selena Alonso, et al.. (2022). Sustained seropositivity up to 20.5 months after COVID-19. BMC Medicine. 20(1). 379–379. 11 indexed citations
15.
Santano, Rebeca, Diana Barrios, F. Crispi, et al.. (2021). Agreement between commercially available ELISA and in-house Luminex SARS-CoV-2 antibody immunoassays. Scientific Reports. 11(1). 18984–18984. 11 indexed citations
16.
Casas, Maribel, Raquel García‐Esteban, Jordi Sunyer, et al.. (2021). Associations between pre- and postnatal exposure to air pollution and lung health in children and assessment of CC16 as a potential mediator. Environmental Research. 204(Pt A). 111900–111900. 15 indexed citations
17.
Vidal, Marta, Chenjerai Jairoce, Ruth Aguilar, et al.. (2020). Antibody responses to the RTS,S/AS01E vaccine and Plasmodium falciparum antigens after a booster dose within the phase 3 trial in Mozambique. npj Vaccines. 5(1). 46–46. 16 indexed citations
18.
Ubillos, Itziar, Ruth Aguilar, Héctor Sanz, et al.. (2018). Analysis of factors affecting the variability of a quantitative suspension bead array assay measuring IgG to multiple Plasmodium antigens. PLoS ONE. 13(7). e0199278–e0199278. 7 indexed citations
20.
Gulson, Brian L., Kathryn R. Mahaffey, Marta Vidal, et al.. (1997). Dietary lead intakes for mother/child pairs and relevance to pharmacokinetic models.. Environmental Health Perspectives. 105(12). 1334–1342. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026